Acumen Research and Consulting recently published report titled “Lacrimal Devices Market – Global Industry Analysis, Market Size, Opportunities and Forecast, 2021 – 2028”
NEW YORK, June 07, 2022 (GLOBE NEWSWIRE) -- The global lacrimal devices market size is estimated to grow a CAGR above 4% over the forecast timeframe and reach a market value of around USD 180 million by 2028.
Tears play a crucial role in the proper functioning of the eye. They protect the eye from inflammation, lubricate eye and eyelid movements, and maintain the existence of a relatively thin film on the surface of the conjunctiva. The tear film is essential for the eye to function as an optical organ. The lacrimal apparatus's purpose is to produce tears, channel them to the layer of the cornea where they keep moisture in place and flush debris and unwanted material from the ocular surface. Tear control is subject to a plethora of inputs and sensory responses. Furthermore, diseases such as dry eye, glaucoma, drainage obstruction, epiphora, and lacrimal gland inflammation are eye diseases that damage the optic nerve as a result of high-eye pressure and can lead to loss of sight. However, with the increasing prevalence of these diseases, the demand for lacrimal devices is increasing. Lacrimal devices aid in keeping the eyes moist and free of dust and fine particles.
Request for a sample of this premium research report @ https://www.acumenresearchandconsulting.com/request-sample/2912
Global Lacrimal Devices Market Growth Aspects
The number of people suffering from massive eye diseases is increasing worldwide and vision loss is becoming a major public health problem. The increasing prevalence of chronic diseases has greatly increased the occurrence of eye problems and ocular hypertension, and the demand for disease treatment is expected to increase in the coming years. As a result, the demand for the lacrimal devices market is growing. Additionally, the increasing adoption of advanced and non-invasive technologies is driving the growth of the market. Moreover, the global geriatric population is projected to more than double from 52 million in 2018 to 94 million in 2060, driving the market growth. Due to improved product efficacy, lacrimal devices are now more productive and are a relatively simple procedure for the management of lacrimal duct obstruction, which is expected to create more revenue generation opportunities.
The increased awareness and accessibility of lacrimal devices, as well as their widespread adoption, are expected to generate significant revenue. Furthermore, the majority of lacrimal device manufacturers are based in developed regions such as Europe and North America. Developing and underdeveloped regions such as Latin America, the Middle East, and South Asia generally depend on Western manufacturers. As a result, device availability is limited in several potentially high-revenue locations, limiting the market growth.
Report Coverage
| Market | Lacrimal Devices Market |
| Market Size 2021 | US$ 142 Mn |
| Market Forecast 2028 | US$ 185 Mn |
| CAGR | 3.9% During 2021 – 2028 |
| Analysis Period | 2021 - 2028 |
| Base Year | 2020 |
| Forecast Data | 2021 – 2028 |
| Segments Covered | By Product, By Application, By End Use, And By Geography |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled | BVI Medical, Bess Medical Technology GmbH, FCI Ophthalmic, Aurolab, Gunther Weiss Scientific, Kaneka Corporation, Lacrimedics, Rumex International, Cook Medical LLC, and Sinopsys Surgical, Inc. |
| Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
| Customization Scope | 10 hrs of free customization and expert consultation |
Rising cases of glaucoma contribute to market growth
For people over the age of 60, glaucoma has become one of the leading causes of disability. Glaucoma is a disease that can damage the optic nerve in the eyes. This damage is caused primarily by abnormally high eye pressure. Furthermore, if untreated, glaucoma will eventually lead to vision loss. Even with therapy, about 15% of glaucoma patients will lose vision in at least one eye within two decades. According to the study, approximately 76 million people would suffer from glaucoma by 2020, with that number expected to increase to 111.8 million by 2040. As a result, the accessibility of superior glaucoma healing, as well as the utilization of glaucoma drainage implant gear, counting lacrimal devices, is expected to drive market demand.
To receive personalized service, please share your research needs here @ https://www.acumenresearchandconsulting.com/request-customization/2912
Regional Overview
North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa are the regional classification of the global lacrimal devices market. Throughout the forecasted years, the Asia-Pacific region is expected to exhibit significant growth rate of the lacrimal device market. The huge affected person in highly populated countries like India and China, which are susceptible to numerous kinds of eye diseases like glaucoma and dry eye, will drive market growth. Furthermore, the growing existence of large numbers of domestic companies in the Asia-Pacific will drive market revenue. China is dominating the Asia-Pacific market due to increased per capita healthcare expenses and several government programs for integrated treatment systems in the region. Moreover, due to continued focus to improve surgical device rules and regulations and increased public awareness about surgeries in the incident of lacrimal duct obstruction and other eye-related diseases, India has grown substantially during the forecasting timeframe.
Market Segmentation
The global lacrimal devices market has been segmented by Acumen Research and Consulting based on product, application and end-use. Based on the product, the market is divided into stents, punctal plugs, intubation sets, dilator, tubes, cannula & spatula, and others. Based on application, the market split into glaucoma, dry eye, lacrimal gland inflammation, drainage obstruction, epiphora, and others. Based on end-use, the market is classified into ophthalmic clinics, hospitals, diagnostic centers, and others.
Don’t fail to benefit from business opportunities in Lacrimal Devices Market. Speak to our analyst, ask any queries and our analyst will help your business grow.
Major Players
Some key players covered global in the lacrimal devices industry are FCI Ophthalmic, Aurolab, Kaneka Corporation, BVI Medical, Gunther Weiss Scientific, Lacrimedics, Rumex International, Cook Medical LLC, Sinopsys Surgical, Inc. and Bess Medical Technology GmbH.
Browse Healthcare and Pharmaceuticals Industry Report
The global mesenchymal stem cell market is expected to grow at a CAGR of around 7.1% from 2020 to 2027 and expected to reach the market value of around US$ 2,600.5 Mn by 2027.
The radiation oncology market is expected to grow at a CAGR of around 7.1% from 2020 to 2027 and expected to reach the market value of around US$ 11.0 Bn by 2027.
Buy this premium research report - https://www.acumenresearchandconsulting.com/buy-now/0/2912
About Acumen:
Acumen Research and Consulting is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
Contact Us:
Mr. Richard Johnson
Acumen Research and Consulting
USA: +14079154157
India: +918983225533
E-mail: sales@acumenresearchandconsulting.com
Official Press Release: https://www.acumenresearchandconsulting.com/press-releases/lacrimal-device-market
Via GlobeNewswire RSS Feed https://ift.tt/Vcm4jTM